A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

October 31, 2006

Conditions
Migraine
Interventions
DRUG

eletriptan

Trial Locations (33)

Unknown

Pfizer Investigational Site, Edmonton

Pfizer Investigational Site, Chilliwack

Pfizer Investigational Site, Coquitlam

Pfizer Investigational Site, Langley

Pfizer Investigational Site, North Vancouver

Pfizer Investigational Site, Penticton

Pfizer Investigational Site, Winnipeg

Pfizer Investigational Site, Bathurst

Pfizer Investigational Site, Moncton

Pfizer Investigational Site, St. John's

Pfizer Investigational Site, Halifax

Pfizer Investigational Site, Truro

Pfizer Investigational Site, Bolton

Pfizer Investigational Site, Brampton

Pfizer Investigational Site, Corunna

Pfizer Investigational Site, Fort Erie

Pfizer Investigational Site, Hamilton

Pfizer Investigational Site, London

Pfizer Investigational Site, Markham

Pfizer Investigational Site, Mississauga

Pfizer Investigational Site, Newmarket

Pfizer Investigational Site, Niagara Falls

Pfizer Investigational Site, Woodstock

Pfizer Investigational Site, Montague

Pfizer Investigational Site, Cowansville

Pfizer Investigational Site, Drummondville

Pfizer Investigational Site, Granby

Pfizer Investigational Site, Montreal

Pfizer Investigational Site, Québec

Pfizer Investigational Site, Sainte-Julie

Pfizer Investigational Site, Sherbrooke

Pfizer Investigational Site, Regina

Pfizer Investigational Site, Mount Pearl

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00174395 - A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine | Biotech Hunter | Biotech Hunter